Literature DB >> 27260794

Successful modulation of portal inflow by somatostatin in a porcine model of small-for-size syndrome.

Kayvan Mohkam1, Benjamin Darnis2, Zoé Schmitt3, Serge Duperret3, Christian Ducerf2, Jean-Yves Mabrut4.   

Abstract

BACKGROUND: Somatostatin may prevent the small-for-size syndrome in subjects undergoing extended hepatectomy by decreasing portal pressure.
METHODS: Twenty pigs underwent 70% hepatectomy (H70 group, n = 7), 90% hepatectomy (H90 group, n = 7), or sham laparotomy (control group, n = 6). Splanchnic hemodynamics was measured before and after an intraoperative infusion of somatostatin.
RESULTS: The portal vein flow normalized to liver weight increased in both H70 and H90 groups (from 125 ± 42 to 342 ± 82 mL/min/100g, P = .031 and from 140 ± 46 to 530 ± 241, P = .016, respectively). The hepatic venous pressure gradient (HVPG) increased in the H90 group only (from 5.5 ± 5.8 to 13 ± 4.9 mm Hg, P = .004). Somatostatin decreased portal vein flow normalized to liver weight in both H70 and H90 groups (from 408 ± 224 to 360 ± 227 mL/min/100g, P = .031 and from 560 ± 190 to 466 ± 189 mL/min/100g, P = .016), and restored a normal HVPG in the H90 group (from 14.3 ± 4.8 to 7.7 ± 6.1 mm Hg, P = .047).
CONCLUSIONS: Somatostatin restores a normal HVPG in the setting of small-for-size syndrome and can be considered as an effective pharmaceutical modality of portal inflow modulation after extended hepatectomy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatectomy; Portal inflow; Small-for-size syndrome; Somatostatin; Swine

Mesh:

Substances:

Year:  2016        PMID: 27260794     DOI: 10.1016/j.amjsurg.2016.01.043

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  7 in total

1.  Hepatic Hemodynamic Changes After Liver Resection: a Reflection of the Complex Relationship Between Portal Vein Flow, Hepatic Artery Flow and Portal Pressure.

Authors:  Kayvan Mohkam; Benjamin Darnis; Jean-Yves Mabrut
Journal:  J Gastrointest Surg       Date:  2016-09-12       Impact factor: 3.452

2.  Reply: Hepatic Hemodynamic Changes Following Stepwise Liver Resection (Golriz et al. J Gastrointest Surg (2016) 20:587-594).

Authors:  Mohammad Golriz; Ali Majlesara; Elias Khajeh; Arianeb Mehrabi
Journal:  J Gastrointest Surg       Date:  2016-09-07       Impact factor: 3.452

3.  Establishing a Porcine Model of Small for Size Syndrome following Liver Resection.

Authors:  Mohammad Golriz; Maryam Ashrafi; Elias Khajeh; Ali Majlesara; Christa Flechtenmacher; Arianeb Mehrabi
Journal:  Can J Gastroenterol Hepatol       Date:  2017-08-29

4.  Comment on "Establishing a Porcine Model of Small for Size Syndrome following Liver Resection".

Authors:  Antonios Athanasiou; Eleftherios Spartalis; Mairead Hennessy; Michael Spartalis; Emmanouil Pikoulis
Journal:  Can J Gastroenterol Hepatol       Date:  2018-05-22

5.  Evaluation of postoperative ascites after somatostatin infusion following hepatectomy for hepatocellular carcinoma by laparotomy: a multicenter randomized double-blind controlled trial (SOMAPROTECT).

Authors:  Kayvan Mohkam; Michel Rayar; Jean-Philippe Adam; Fabrice Muscari; Agnès Rode; Philippe Merle; Pierre Pradat; Stéphanie Bauler; Isabelle Delfour; Laurence Chiche; Christian Ducerf; Karim Boudjema; Mickaël Lesurtel; Christophe Laurent; Jean-Yves Mabrut
Journal:  BMC Cancer       Date:  2018-08-23       Impact factor: 4.430

Review 6.  Somatostatin and the "Small-For-Size" Liver.

Authors:  Amelia J Hessheimer; Lilia Martínez de la Maza; Farah Adel Al Shwely; Arlena Sofía Espinoza; Fabio Ausania; Constantino Fondevila
Journal:  Int J Mol Sci       Date:  2019-05-22       Impact factor: 5.923

7.  Effects of propofol and sevoflurane on hepatic blood flow: a randomized controlled trial.

Authors:  Jurgen van Limmen; Piet Wyffels; Frederik Berrevoet; Aude Vanlander; Laurent Coeman; Patrick Wouters; Stefan De Hert; Luc De Baerdemaeker
Journal:  BMC Anesthesiol       Date:  2020-09-22       Impact factor: 2.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.